Nuveen »

An2 Therapeutics shares owned by Nuveen

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Nuveen

Quarter filed Position value Share count Share price at filing
2026-06-30 $171k 35k 4.84

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Advanced Micro Devices (AMD)

View all positions for Nuveen

Top funds holding An2 Therapeutics

Vivo Capital
Commodore Capital
Millennium Management
BlackRock
Spruce Street Capital
Almitas Capital
Vanguard Capital Management
Adage Capital Partners GP
Citadel Advisors
Boxer Capital Management
Geode Capital Management
SummitTX Capital
Balyasny Asset Management
Stonepine Capital Management
Ameriprise Financial

View all funds holding An2 Therapeutics